- If the semi-con recovery ramps up in 2H24, we believe Frencken (SGX:E28) will be a key beneficiary and profitability could even surge beyond our bullish forecast.
- Frencken’s 4Q23 PATMI of S$13m was significantly higher than our and consensus estimates (S$7-8m), mainly due to higher orders from the semicon and medical segments and pull-in orders slated for 1Q24.
Semicon a key segment to watch
- - Read this at SGinvestors.io -
- - Read this at SGinvestors.io -
- 2H24’s performance will depend on whether the semicon industry ramps up. If so, Frencken will likely be a main beneficiary and enjoy stronger profitability than we have forecast.
Gradual sequential recovery
- Read more at SGinvestors.io.
Above is the excerpt from report by Maybank Research.
Clients of Maybank Securities may be the first to access the full report in PDF @ https://maybanktrade.com.sg/.
Jarick Seet Maybank Research | https://www.maybank-ke.com.sg/ 2024-02-28
Previous report by Maybank:
2024-02-16 Frencken - Strengthening Recovery.
Price targets by 4 other brokers at Frencken Target Prices.
Listing of research reports at Frencken Analyst Reports.
Relevant links:
Frencken Share Price History,
Frencken Announcements,
Frencken Dividends & Corporate Actions,
Frencken News Articles
